Skip to main content
SpringerLink
Log in

Gastrointestinal Brachytherapy: Esophageal Cancer

  • Chapter
  • First Online:
Book cover Handbook of Image-Guided Brachytherapy

  • 1580 Accesses

Abstract

High-dose rate (HDR) endoluminal brachytherapy is a safe, effective and well-tolerated option for the treatment of patients with medically inoperable primary and recurrent esophageal tumors. Optimal endoluminal esophageal HDR technique uses a large diameter applicator that allows delivery of adequate dose at prescription depth while limiting the mucosal dose to tolerable levels. Dose is prescribed to a depth from the surface of the catheter, with prescription depth determined on the basis of clinical assessment of tumor thickness. Maximum tolerated dose is currently being determined in the setting of a phase I clinical trial. Several imaging modalities are employed in treatment planning, delivery, and follow-up of endoluminal brachytherapy including CT, MRI, fluoroscopy, X-ray markers, and endoscopy. An overview of the technical aspects of the procedure as well as issues regarding treatment planning, delivery, and follow-up after endoluminal brachytherapy are discussed in this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. American Cancer Society. Cancer facts & figures 2016. Atlanta: American Cancer Society; 2016.

    Google Scholar 

  2. Herskovic A, Martz K, al-Sarraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 1992;326:1593–8.

    Article  CAS  PubMed  Google Scholar 

  3. al-Sarraf M, Martz K, Herskovic A, et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol. 1997;15:277–84.

    Article  CAS  PubMed  Google Scholar 

  4. Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA. 1999;281:1623–7.

    Article  CAS  PubMed  Google Scholar 

  5. Tepper J, Krasna MJ, Niedzwiecki D, et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol. 2008;26:1086–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Stahl M, Walz MK, Stuschke M, et al. Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol. 2009;27:851–6.

    Article  CAS  PubMed  Google Scholar 

  7. Gaspar LE, Nag S, Herskovic A, et al. American Brachytherapy Society (ABS) consensus guidelines for brachytherapy for esophageal cancer. Int J Radiat Oncol Biol Phys. 1997;38:127–32.

    Article  CAS  PubMed  Google Scholar 

  8. Hishikawa Y, Kurisu K, Taniguchi M, et al. High-dose-rate intraluminal brachytherapy for esophageal cancer: 10 years experience in Hyogo College of Medicine. Radiother Oncol. 1991;21:107–14.

    Article  CAS  PubMed  Google Scholar 

  9. Gaspar LE, Winter K, Kocha WI, et al. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207). Cancer. 2000;88:988–95.

    Article  CAS  PubMed  Google Scholar 

  10. Sharma V, Mahantshetty U, Dinshaw KA, et al. Palliation of advanced/recurrent esophageal carcinoma with high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys. 2002;52:310–5.

    Article  PubMed  Google Scholar 

  11. Akagi Y, Hirokawa Y, Kagemoto M, et al. Optimum fractionation for high-dose-rate endoesophageal brachytherapy following external irradiation of early stage esophageal cancer. Int J Radiat Oncol Biol Phys. 1999;43:525–30.

    Article  CAS  PubMed  Google Scholar 

  12. Vuong T, Szego P, David M, et al. The safety and usefulness of high-dose-rate endoluminal brachytherapy as a boost in the treatment of patients with esophageal cancer with external beam radiation with or without chemotherapy. Int J Radiat Oncol Biol Phys. 2005;63:758–64.

    Article  PubMed  Google Scholar 

  13. Nonoshita T, Sasaki T, Hirata H, et al. High-dose-rate brachytherapy for previously irradiated patients with recurrent esophageal cancer. Radiat Med. 2007;25:373–7.

    Article  PubMed  Google Scholar 

  14. Cox BW, Jackson A, Hunt M, et al. Esophageal toxicity from high-dose, single-fraction paraspinal stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2012;83:e661–7.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Folkert M, Cohen G, Wu A, et al. Endoluminal high-dose-rate brachytherapy for early stage and recurrent esophageal cancer in medically inoperable patients. Brachytherapy. 2013;12:463–70.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO, USA

    Supriya K. Jain MD, MHS & Karyn A. Goodman MD, MS

Authors
  1. Supriya K. Jain MD, MHS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karyn A. Goodman MD, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karyn A. Goodman MD, MS .

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology, University of California Davis Medical Center, UC Davis Comprehensive Cancer Center, Sacramento, California, USA

    Jyoti Mayadev

  2. Department of Radiation Oncology, University of California Davis Medical Center, UC Davis Comprehensive Cancer Center, Sacramento, California, USA

    Stanley H. Benedict

  3. Division of Brachytherapy, Gynecologic and Sarcoma Services, Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, California, USA

    Mitchell Kamrava

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Jain, S.K., Goodman, K.A. (2017). Gastrointestinal Brachytherapy: Esophageal Cancer. In: Mayadev, J., Benedict, S., Kamrava, M. (eds) Handbook of Image-Guided Brachytherapy. Springer, Cham. https://doi.org/10.1007/978-3-319-44827-5_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-44827-5_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-44825-1

  • Online ISBN: 978-3-319-44827-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation